Literature DB >> 23838566

12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia.

Robin L Haynes1, Klaus van Leyen.   

Abstract

Oxidative stress involving premyelinating oligodendrocytes (OLs) is a major factor in the pathogenesis of preterm white matter injury. In animal and cell culture studies, activation of the lipid-oxidizing enzyme 12/15-lipoxygenase (12/15-LOX) plays a central role as an inflammatory mediator in the pathology of oxidative stress and OL cell death, as well as ischemia and neuronal death. The role of 12/15-LOX, however, is unclear in the developing human brain. The mechanism of 12/15-LOX involves the production of reactive oxygen species through the metabolism of arachidonic acid, as well as direct detrimental effects on organelle membranes. Here we tested the hypothesis that the density of 12/15-LOX-expressing cells is increased in periventricular leukomalacia (PVL). Using immunocytochemistry (ICC) in human paraffin-embedded tissue, 12/15-LOX expression was seen in macrophages of the focally necrotic lesions in the periventricular white matter, as well as in glial cells throughout the surrounding white matter with reactive gliosis. Interestingly, no significant 12/15-LOX expression was detected in neurons in the cerebral cortex overlying the damaged white matter. Using a scoring system from 0 to 3, we assessed the density of 12/15-LOX-expressing cells in diffusely gliotic white matter from 20 to 43 postconceptional (PC) weeks in 19 PVL cases (median = 36 PC weeks) and 10 control (non-PVL) cases (median = 34 PC weeks). The density of 12/15-LOX-positive cells was significantly increased in the diffuse component of PVL (score = 1.17 ± 0.15) compared to controls (score = 0.48 ± 0.21; p = 0.014). Using double-label ICC, 12/15-LOX was observed in PVL in OLs of the O4 and O1 premyelinating stages, as well as in mature OLs as determined with the mature OL marker adenomatous polyposis coli (APC). In addition, 12/15-LOX expression was present in a population of CD68-positive activated microglia. There was no 12/15-LOX expression in reactive astrocytes. Finally we observed terminal deoxynucleotide transferase dUTP nick end-labeling-positive cells within the white matter of PVL that expressed 12/15-LOX and/or within close proximity of 12/15-LOX-positive cells. Our data support a role for 12/15-LOX activation as an inflammatory mediator of injury in PVL, with a contribution of 12/15-LOX to PVL-induced damage to or cell death of OLs, including those at the O1 and O4 stages.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23838566      PMCID: PMC3860095          DOI: 10.1159/000350230

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  82 in total

Review 1.  Cytosolic phospholipase A2 (cPLA2) and lipid mediator release in the brain.

Authors:  R M Kramer; D T Stephenson; E F Roberts; J A Clemens
Journal:  J Lipid Mediat Cell Signal       Date:  1996-09

Review 2.  The yin and yang of microglia.

Authors:  Melinda Czeh; Pierre Gressens; Angela M Kaindl
Journal:  Dev Neurosci       Date:  2011-07-15       Impact factor: 2.984

3.  12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress.

Authors:  Stefanie Pallast; Ken Arai; Xiaoying Wang; Eng H Lo; Klaus van Leyen
Journal:  J Neurochem       Date:  2009-09-08       Impact factor: 5.372

Review 4.  Inflammation and immune regulation by 12/15-lipoxygenases.

Authors:  Hartmut Kühn; Valerie B O'Donnell
Journal:  Prog Lipid Res       Date:  2006-03-31       Impact factor: 16.195

5.  Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration.

Authors:  Savita Khanna; Sashwati Roy; Hoon Ryu; Praveen Bahadduri; Peter W Swaan; Rajiv R Ratan; Chandan K Sen
Journal:  J Biol Chem       Date:  2003-08-13       Impact factor: 5.157

6.  Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury.

Authors:  S A Back; N L Luo; N S Borenstein; J M Levine; J J Volpe; H C Kinney
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

7.  Expression and regulation of 12/15-lipoxygenases in human primary macrophages.

Authors:  Sophia J A Wuest; Margot Crucet; Claudio Gemperle; Christa Loretz; Martin Hersberger
Journal:  Atherosclerosis       Date:  2012-08-23       Impact factor: 5.162

8.  Distinct isoforms of phospholipase A2 mediate the ability of Salmonella enterica serotype typhimurium and Shigella flexneri to induce the transepithelial migration of neutrophils.

Authors:  Karen L Mumy; Jeffrey D Bien; Michael A Pazos; Karsten Gronert; Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

9.  Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption.

Authors:  Li Sun; Li Yang; Yan-Wei Xu; Hao Liang; Jing Han; Rui-Jie Zhao; Yan Cheng
Journal:  Brain Res       Date:  2012-07-31       Impact factor: 3.252

10.  Infection-induced vulnerability of perinatal brain injury.

Authors:  Carina Mallard; Xiaoyang Wang
Journal:  Neurol Res Int       Date:  2011-11-02
View more
  15 in total

Review 1.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

2.  Human Amnion Epithelial Cells Protect Against White Matter Brain Injury After Repeated Endotoxin Exposure in the Preterm Ovine Fetus.

Authors:  Tamara Yawno; Tharani Sabaretnam; Jingang Li; Courtney McDonald; Rebecca Lim; Graham Jenkin; Euan M Wallace; Suzanne L Miller
Journal:  Cell Transplant       Date:  2016-10-31       Impact factor: 4.064

3.  Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro.

Authors:  Jördis Klose; Lu Li; Xiaohui Fan; Ellen Fritsche; Melanie Pahl; Farina Bendt; Ulrike Hübenthal; Christian Jüngst; Patrick Petzsch; Astrid Schauss; Karl Köhrer; Ping Chung Leung; Chi Chiu Wang; Katharina Koch; Julia Tigges
Journal:  Cell Biol Toxicol       Date:  2022-06-15       Impact factor: 6.691

4.  Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis.

Authors:  Mingqin Zhu; Xiuzhe Wang; Erik Hjorth; Romain A Colas; Lisa Schroeder; Ann-Charlotte Granholm; Charles N Serhan; Marianne Schultzberg
Journal:  Mol Neurobiol       Date:  2015-12-09       Impact factor: 5.590

Review 5.  Mammalian lipoxygenases and their biological relevance.

Authors:  Hartmut Kuhn; Swathi Banthiya; Klaus van Leyen
Journal:  Biochim Biophys Acta       Date:  2014-10-12

Review 6.  12/15 Lipoxygenase as a Therapeutic Target in Brain Disorders.

Authors:  Hulya Karatas; Canan Cakir-Aktas
Journal:  Noro Psikiyatr Ars       Date:  2019-09-05       Impact factor: 1.339

7.  Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.

Authors:  Ganesha Rai; Netra Joshi; Joo Eun Jung; Yu Liu; Lena Schultz; Adam Yasgar; Steve Perry; Giovanni Diaz; Qiangli Zhang; Victor Kenyon; Ajit Jadhav; Anton Simeonov; Eng H Lo; Klaus van Leyen; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2014-05-13       Impact factor: 7.446

8.  A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.

Authors:  Weiping Su; Steven Matsumoto; Fatima Banine; Taasin Srivastava; Justin Dean; Scott Foster; Peter Pham; Brian Hammond; Alec Peters; Kesturu S Girish; Kanchugarakoppal S Rangappa; Joachim Jose; Jon D Hennebold; Melinda J Murphy; Jill Bennett-Toomey; Stephen A Back; Larry S Sherman
Journal:  Glia       Date:  2019-09-06       Impact factor: 7.452

9.  Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway.

Authors:  Dennis Y Chuang; Agnes Simonyi; Paul T Kotzbauer; Zezong Gu; Grace Y Sun
Journal:  J Neuroinflammation       Date:  2015-10-31       Impact factor: 8.322

10.  Identification of key molecular biomarkers involved in reactive and neurodegenerative processes present in inherited congenital hydrocephalus.

Authors:  Patricia Páez-González; Antonio J Jiménez; Betsaida Ojeda-Pérez; José A Campos-Sandoval; María García-Bonilla; Casimiro Cárdenas-García
Journal:  Fluids Barriers CNS       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.